Skip to main content
SpringerLink
Log in

Pre-exposure prophylaxis for high-risk MSM cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Reitsema M, et al. Pre-exposure prophylaxis for MSM in the Netherlands: impact on HIV and N. gonorrhoeae transmission and cost-effectiveness. AIDS : 27 Dec 2019. Available from: URL: http://doi.org/10.1097/QAD.0000000000002469

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pre-exposure prophylaxis for high-risk MSM cost effective. PharmacoEcon Outcomes News 845, 27 (2020). https://doi.org/10.1007/s40274-020-6530-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6530-1

Search

Navigation